Charlotte, North Carolina-based Albemarle Corporation (ALB) develops, manufactures, and markets engineered specialty chemicals worldwide. With a market cap of $11.4 billion, Albemarle operates through Energy Storage, Specialties, and Ketjen segments.
Specialty chemical giant Albemarle has notably underperformed the broader market over the past year. ALB stock prices have gained 12.9% on a YTD basis and declined 2.8% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 14.4% gains in 2025 and 12.7% returns over the past year.
